ATA8589A - Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel - Google Patents

Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel

Info

Publication number
ATA8589A
ATA8589A AT0008589A AT8589A ATA8589A AT A8589 A ATA8589 A AT A8589A AT 0008589 A AT0008589 A AT 0008589A AT 8589 A AT8589 A AT 8589A AT A8589 A ATA8589 A AT A8589A
Authority
AT
Austria
Prior art keywords
cephalosporine
crystalline
salt
pharmaceutical agent
containing pharmaceutical
Prior art date
Application number
AT0008589A
Other languages
English (en)
Other versions
AT399878B (de
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22510643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA8589(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ATA8589A publication Critical patent/ATA8589A/de
Application granted granted Critical
Publication of AT399878B publication Critical patent/AT399878B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0008589A 1988-01-19 1989-01-18 Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel AT399878B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/144,899 US4910301A (en) 1985-08-05 1988-01-19 Cefepime cephalosporin salts

Publications (2)

Publication Number Publication Date
ATA8589A true ATA8589A (de) 1994-12-15
AT399878B AT399878B (de) 1995-08-25

Family

ID=22510643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0008589A AT399878B (de) 1988-01-19 1989-01-18 Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel

Country Status (32)

Country Link
US (1) US4910301A (de)
JP (1) JPH0725768B2 (de)
KR (1) KR950003612B1 (de)
AT (1) AT399878B (de)
AU (1) AU615509B2 (de)
BE (1) BE1002749A5 (de)
CA (1) CA1298288C (de)
CY (1) CY1663A (de)
CZ (1) CZ281602B6 (de)
DD (2) DD284807A5 (de)
DE (1) DE3901359A1 (de)
DK (1) DK162054C (de)
EG (1) EG18749A (de)
ES (1) ES2012948A6 (de)
FI (1) FI86854C (de)
FR (1) FR2626003B1 (de)
GB (1) GB2213819B (de)
GR (1) GR1001218B (de)
HK (1) HK72292A (de)
HU (1) HU205940B (de)
IE (1) IE67447B1 (de)
IT (1) IT1229528B (de)
LU (1) LU87432A1 (de)
NL (1) NL192266C (de)
NZ (1) NZ227605A (de)
OA (1) OA09227A (de)
PT (1) PT89474B (de)
SE (1) SE505258C2 (de)
SG (1) SG75492G (de)
SK (1) SK281768B6 (de)
YU (1) YU221188A (de)
ZA (1) ZA89407B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
EP0376185B1 (de) * 1988-12-27 1994-08-17 Chugai Seiyaku Kabushiki Kaisha Reinigungsverfahren für 1,2-Bis(nicotinamido)propan
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
CA2099692C (en) * 1992-07-24 2003-09-30 Gary M. F. Lim Process for preparing cephalosporin intermediates
US5391729A (en) * 1992-09-08 1995-02-21 Bristol-Myers Squibb Company Crystalline dihydrate of a cephalosporin salt
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
US20070111980A1 (en) * 2004-07-16 2007-05-17 Bandi Parthasaradhi Reddy Process for preparing pure cephalosporine intermediates
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi
ITMI20060422A1 (it) * 2006-03-09 2007-09-10 Harvest Lodge Ltd Procedimento diretto per la produzione del dicloridrato di un amminoacido
US8151846B2 (en) * 2006-12-15 2012-04-10 Center Line Wheel Corporation Wheel having inner bead-lock
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
CN103304580B (zh) * 2013-06-09 2014-07-09 四川省惠达药业有限公司 一种盐酸头孢吡肟化合物、其制备方法及其药物组合物
WO2017096472A1 (en) * 2015-12-10 2017-06-15 Naeja-Rgm Pharmaceuticals Inc. Cephem compounds, their production and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
IT1145686B (it) * 1979-05-25 1986-11-05 Glaxo Group Ltd Intermedi per la preparazione di antibiotici cefalosporinici e procedimento per prepararli
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4751295A (en) * 1984-04-09 1988-06-14 Bristol-Myers Company Cephalosporin derivatives
US4749694A (en) * 1984-04-26 1988-06-07 Merck & Co., Inc. Novel lysine esters used as absorption
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US4791196A (en) * 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt

Also Published As

Publication number Publication date
SE505258C2 (sv) 1997-07-21
GB8901073D0 (en) 1989-03-15
HUT50347A (en) 1990-01-29
OA09227A (fr) 1992-06-30
DK20789A (da) 1989-07-20
LU87432A1 (fr) 1989-08-30
FI86854C (fi) 1992-10-26
PT89474B (pt) 1993-12-31
CY1663A (en) 1993-05-14
JPH0725768B2 (ja) 1995-03-22
NZ227605A (en) 1991-06-25
EG18749A (en) 1993-12-30
SK24389A3 (en) 2000-12-11
GR1001218B (el) 1993-06-21
AU2862389A (en) 1989-07-20
CZ24389A3 (en) 1996-08-14
US4910301A (en) 1990-03-20
DK20789D0 (da) 1989-01-18
IT8947539A0 (it) 1988-01-17
ZA89407B (en) 1989-09-27
ES2012948A6 (es) 1990-04-16
DK162054C (da) 1992-02-10
IT1229528B (it) 1991-09-04
KR890011895A (ko) 1989-08-23
CA1298288C (en) 1992-03-31
DD284807A5 (de) 1990-11-28
IE890144L (en) 1989-07-19
SE8900173D0 (sv) 1989-01-18
YU221188A (en) 1990-04-30
SK281768B6 (sk) 2001-07-10
GB2213819A (en) 1989-08-23
GB2213819B (en) 1991-11-27
BE1002749A5 (fr) 1991-05-28
DD283397A5 (de) 1990-10-10
FI890213A (fi) 1989-07-20
FR2626003B1 (fr) 1992-10-16
HU205940B (en) 1992-07-28
JPH029885A (ja) 1990-01-12
DE3901359A1 (de) 1989-10-05
NL192266B (nl) 1996-12-02
FR2626003A1 (fr) 1989-07-21
IE67447B1 (en) 1996-04-03
FI86854B (fi) 1992-07-15
SE8900173L (en) 1989-01-18
HK72292A (en) 1992-10-02
NL8900111A (nl) 1989-08-16
CZ281602B6 (cs) 1996-11-13
FI890213A0 (fi) 1989-01-16
AT399878B (de) 1995-08-25
AU615509B2 (en) 1991-10-03
DK162054B (da) 1991-09-09
SG75492G (en) 1992-10-02
DE3901359C2 (de) 1992-04-30
KR950003612B1 (ko) 1995-04-17
NL192266C (nl) 1997-04-03
PT89474A (pt) 1990-02-08

Similar Documents

Publication Publication Date Title
AT399878B (de) Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel
KR900701258A (ko) 결장 선택적 방출성을 갖는 경구용 약제학적 제제
DK229489D0 (da) Laegemiddeladsorbater
NZ215850A (en) Heterocyclic amides and pharmaceutical compositions thereof
NZ220120A (en) Heterocyclic benzamide derivatives and pharmaceutical composistions
DK489189D0 (da) Farmaceutisk praeparat
EP0193415A3 (en) Spiro-3-heteroazolidine compounds and salts thereof, their preparation and pharmaceutical agents thereof
DK313989A (da) Farmaceutisk praeparat mod atherosclerose
ATA901089A (de) Benzazepin- und benzothiazepinderivate und deren salze
DE69030030T2 (de) 4-Acyloxychinolin-Derivate und diese enthaltende insektizide und akarizide Mittel
DE68926733D1 (de) Piperidin-Derivate und diese enthaltende Hypotensiva
DE68909501T2 (de) Hydroxyalkylcystein-Derivate und diese enthaltende Expectoranzien.
DK548689D0 (da) Farmaceutisk oploesning
DK336489D0 (da) Farmaceutisk praeparat
DE3889198T2 (de) Cephalosporinverbindungen und antibakterielle Mittel.
DE3674017D1 (de) Oxalursaeure-derivate und pharmazeutisches mittel.
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
EP0239062A3 (en) N2-(1-carboxy-3-oxo-3-phenylpropyl)-l-lysine compounds and their derivatives
DE3885781D1 (de) Aluminiumsalz und dieses enthaltendes Antiperspirans.
DK52186D0 (da) Farmaceutisk praeparat indeholdende indolderivater
KR890017050U (ko) 일회용 치솔
KR900011430U (ko) 1회용 치솔
ZA892224B (en) Organic compounds and their pharmaceutical use
PT83874A (de) Phosphoverbindungen und diese enthaltende arzneimittel
ATE97568T1 (de) Aluminiumsalz und dieses enthaltendes antiperspirans.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee